{
  "resourceType" : "Medication",
  "id" : "ImmunosuppressantBasiliximab1",
  "meta" : {
    "profile" : ["https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/StructureDefinition/immunosuppressant"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Medication ImmunosuppressantBasiliximab1</b></p><a name=\"ImmunosuppressantBasiliximab1\"> </a><a name=\"hcImmunosuppressantBasiliximab1\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-immunosuppressant.html\">Immunosuppressant</a></p></div><p><b>identifier</b>: <a href=\"NamingSystem-NsProtectChildId.html\" title=\"Single identifier namespace for PROTECT-CHILD record business identifiers (patient, donor, visit, transplant, and all per-visit clinical/lab/medication/specimen/event records). The resource type distinguishes the kind of record. Identifiers follow one convention: TOKEN-CENTRE-SEQUENCE, for example REC-1-0001 (patient, centre 1, sequence 1) or LBR-1-0006 (lab result); study-wide catalogue entries such as lab tests are not centre-qualified and use TOKEN-SEQUENCE, for example LBT-0001. Identifiers carry no clinical meaning.\">ProtectChildId</a>/IMM-0003</p><p><b>code</b>: <span title=\"Codes:{https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/CodeSystem/immunosuppressant-drug-type-cs 19038440}\">Basiliximab</span></p><p><b>status</b>: Active</p></div>"
  },
  "identifier" : [{
    "system" : "https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/NamingSystem/protect-child-id",
    "value" : "IMM-0003"
  }],
  "code" : {
    "coding" : [{
      "system" : "https://hl7.eu/fhir/ig/hl7.eu.fhir.protect-child/CodeSystem/immunosuppressant-drug-type-cs",
      "code" : "19038440",
      "display" : "Basiliximab"
    }]
  },
  "status" : "active"
}